- Governor Abbott halted new H-1B petitions for Texas public agencies and universities without state approval.
- The freeze impacts over three thousand H-1B employees across forty-four major research and medical institutions.
- New federal policies impose one-hundred-thousand-dollar fees and fixed four-year stay limits for international researchers.
Texas Governor Greg Abbott ordered state agencies and public universities to stop filing new H-1B petitions without written permission, putting a new barrier in front of public medical research employers and the foreign specialists they recruit.
The directive took effect January 27, 2026, and remains scheduled through May 31, 2027. The Texas Workforce Commission must approve petitions before state institutions can submit them.
The restriction reaches major research centers. Records show MD Anderson Cancer Center sponsors 277 H-1B workers, while 44 public institutions across Texas report 3,332 H-1B employees in total.
Free toolH-1B Cost Calculator OnlineThe pipeline is already tight. Advocates warn that blocking new hires could delay clinical trials and specialized artificial-intelligence tissue analysis.
Texas has invested billions in cancer research infrastructure. Foreign-born researchers account for more than 40% of the biomedical graduate-student pool and at least 50% of postdoctoral trainees.
| India | China | ROW | |
|---|---|---|---|
| EB-1 | Oct 15, 2022 | Jul 01, 2023 ▲30d | Current |
| EB-2 | Unavailable | Sep 01, 2021 | Current |
| EB-3 | Jan 01, 2014 | Jan 01, 2022 ▲10d | Sep 01, 2024 ▲31d |
| F-1 | Dec 15, 2018 ▲317d | Dec 15, 2018 ▲317d | Dec 15, 2018 ▲317d |
| F-2A | Jul 22, 2026 ▲567d | Jul 22, 2026 ▲567d | Jul 22, 2026 ▲567d |
Lore Gruenbaum, chief scientific officer at Blood Cancer United, said Wednesday that the restrictions send a “chilling message” to young scientists considering Texas institutions.
A separate federal charge raises the cost of recruiting researchers from abroad. A presidential proclamation effective September 21, 2025, imposed a one-time $100,000 fee on many new applications for workers outside the United States.
Texas employers now need state approval before opening new H-1B cases
The state order affects public employers, not only hospitals. State agencies and public universities must seek written permission before filing petitions, and that requirement remains in place until the scheduled end of the freeze.
The immediate exposure is concentrated among institutions that depend on specialized research staff. The reported totals show the scale:
| Texas public institutions | H-1B workers |
|---|---|
| MD Anderson | 277 |
| 44 institutions combined | 3,332 |
The figures describe existing sponsorship, not a forecast of layoffs or visa cancellations. The stated concern is what happens when institutions cannot add researchers to teams already running trials or developing new analysis methods.
Rare-cancer programs face a particular risk. Only a few research teams worldwide may have the expertise needed to advance treatments in some of those diseases, advocates say.
The state restriction operates alongside several federal changes. Each creates a different problem for employers and workers.
Federal policies add cost and delay to the recruitment pipeline
Since January 1, 2026, U.S. Citizenship and Immigration Services has maintained a broad adjudicative hold on applications from nationals of 39 designated “high-risk” countries under Presidential Proclamation 10998.
USCIS added “medical physicians” to a priority hold-lift review process on April 30, 2026. The move aimed to advance physician cases delayed by broader adjudication pauses, offering a targeted route for part of the health-care workforce.
The relief does not remove the state permission requirement. A public institution still needs Texas approval before filing a new petition.
Recruiters also face the federal fee for many workers outside the country. At $100,000, that payment can make an overseas hire unaffordable for an academic laboratory, particularly when the institution must recruit several specialists.
The policies therefore affect different stages. Texas controls whether a public employer may file, while federal authorities control adjudication and impose costs on covered applications.
A four-year limit is coming for F-1, J-1 and I researchers
The Department of Homeland Security finalized another rule on July 17, 2026. It replaces the longstanding Duration of Status policy with fixed-term admission of no more than four years for F-1, J-1 and I visa holders.
The rule takes effect September 15, 2026. Researchers in long doctoral programs or medical residencies will need to apply for an Extension of Status when their programs continue beyond the fixed period.
Critics say the additional applications could make it harder for Texas institutions to retain biomedical talent. The rule reaches a separate group from H-1B workers, but it affects the same research and training pipeline.
DHS Secretary Markwayne Mullin, who was confirmed on March 24, 2026, has emphasized stricter enforcement. On June 8, 2026, he said:
“American citizenship is a privilege, and it must be earned honestly. If you come here break our laws. you forfeit that privilege. DHS will not stand idly by while Americans are harmed. we will continue to use every lawful avenue to denaturalize and remove [those who exploit the system].”
That statement addressed citizenship enforcement rather than cancer research or H-1B petitions. It reflects the administration’s broader “zero-tolerance” approach to program abuse during the period when research employers are managing new immigration constraints.
The next fixed date is September 15. Texas’ approval freeze is scheduled to continue until May 31, 2027.
